The Effect of Percussion Massage Therapy in Stroke Patients

NCT07454655 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-03-06

No results posted yet for this study

Summary

Stroke is an acute neurological condition resulting from cerebral ischemia or hemorrhage, frequently leading to impaired motor function, increased muscle tone, and deficits in balance and gait. Spasticity is a common long-term complication in individuals with chronic stroke and significantly affects functional mobility and quality of life.

Percussion Massage Therapy (PMT) is an emerging intervention that combines principles of mechanical vibration and traditional soft tissue techniques. Although previous research has examined its effects in musculoskeletal and athletic populations, evidence regarding its use in individuals with chronic stroke remains limited.

The aim of this study is to investigate the effects of percussion massage therapy on muscle tone in individuals with chronic stroke and to determine whether changes in muscle tone are associated with improvements in gait and balance performance.

Conditions

  • Stroke
  • Viscoelastic Property
  • Rehabilitation

Interventions

OTHER

exercises

Treatment for both groups will last for 6 weeks, 3 days a week, with each session lasting approximately 45-60 minutes. Assessment sessions will last 30-40 minutes and will be conducted independently of the treatment sessions. Assessment sessions will be conducted twice, before and after treatment. The Classical Physiotherapy Programme applied to both groups will consist of stretching exercises, strengthening exercises, walking and balance training, and neuromuscular electrical stimulation applied to the lower extremity muscles. Percussion Massage Therapy (PMT), which will be applied in addition to the experimental group, will be applied to the hip adductors, knee extensors, and ankle plantar flexors belonging to the lower extremity extensor synergy. Application Method: PMT will be applied to each muscle group of the lower extremity for 2-3 minutes.

Sponsors & Collaborators

  • Sanko University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-30
Primary Completion
2026-03-15
Completion
2026-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454655 on ClinicalTrials.gov